Paper33845554
Mismatch repair deficiency and clinicopathological characteristics in endometrial carcinoma: a systematic review and meta-analysis.
Jumaah AS and 4 others. J Pathol Transl Med, 2021. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Mismatch repair deficiency and clinicopathological characteristics in endometrial carcinoma: a systematic review and meta-analysis. Papers, record 33845554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33845554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mismatch repair deficiency and clinicopathological characteristics in endometrial carcinoma: a systematic review and meta-analysis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28067827 | Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28067827 | PubMed |
| 2 | 18624996 | Molecular epidemiological and mutational analysis of DNA mismatch repair (MMR) genes in endometrial cancer patients with HNPCC-associated familial predisposition to cancer. | Cancer Sci | 2008 | https://conductscience.org/library/papers/18624996 | PubMed |
| 3 | 23599155 | Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non-endometrioid carcinomas. | Mod Pathol | 2013 | https://conductscience.org/library/papers/23599155 | PubMed |
| 4 | 30332563 | Molecular Genetics of Endometrial Carcinoma. | Annu Rev Pathol | 2019 | https://conductscience.org/library/papers/30332563 | PubMed |
| 5 | 30616900 | Endocrine therapy in endometrial cancer: An old dog with new tricks. | Gynecol Oncol | 2019 | https://conductscience.org/library/papers/30616900 | PubMed |
| 6 | 25554246 | Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. | Syst Rev | 2015 | https://conductscience.org/library/papers/25554246 | PubMed |
| 7 | 30115102 | The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol. | Syst Rev | 2018 | https://conductscience.org/library/papers/30115102 | PubMed |
| 8 | 16323174 | Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma. | Cancer | 2006 | https://conductscience.org/library/papers/16323174 | PubMed |
| 9 | 30415991 | Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression. | Gynecol Oncol | 2019 | https://conductscience.org/library/papers/30415991 | PubMed |
| 10 | 31086306 | The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis. | Genet Med | 2019 | https://conductscience.org/library/papers/31086306 | PubMed |
| 11 | 25229768 | Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. | Am J Surg Pathol | 2014 | https://conductscience.org/library/papers/25229768 | PubMed |
| 12 | 11391585 | Clinicopathologic and familial characteristics of endometrial carcinoma with multiple primary carcinomas in relation to the loss of protein expression of MSH2 and MLH1. | Cancer | 2001 | https://conductscience.org/library/papers/11391585 | PubMed |
| 13 | 24323032 | Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. | J Clin Oncol | 2014 | https://conductscience.org/library/papers/24323032 | PubMed |
| 14 | 28061006 | Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer. | Cancer | 2017 | https://conductscience.org/library/papers/28061006 | PubMed |
| 15 | 32867011 | The frequency of POLE-mutation in endometrial carcinoma and prognostic implications: a systemic review and meta-analysis. | J Pathol Transl Med | 2020 | https://conductscience.org/library/papers/32867011 | PubMed |
| 16 | 20498393 | Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20498393 | PubMed |
| 17 | 22287095 | Loss of HLA class I and mismatch repair protein expression in sporadic endometrioid endometrial carcinomas. | Int J Cancer | 2012 | https://conductscience.org/library/papers/22287095 | PubMed |
| 18 | 11042571 | Clinical significance of microsatellite instability in endometrial carcinoma. | Cancer | 2000 | https://conductscience.org/library/papers/11042571 | PubMed |
| 19 | 17527071 | Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators. | Am J Surg Pathol | 2007 | https://conductscience.org/library/papers/17527071 | PubMed |
| 20 | 22007046 | QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. | Ann Intern Med | 2011 | https://conductscience.org/library/papers/22007046 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42589531 | Prevalence of Mismatch Repair Deficiency and Its Association with Histopathological Parameters in Endometrial Cancer: A Prospective Cohort Study. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589531 | PubMed |
| 42474655 | Deciphering survival disparities in endometrial cancer: a focus on mismatch repair pathway integrity (systematic review and meta-analysis). | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42474655 | PubMed |
| 41899533 | Prognostic Stratification of Multiple-Classifier Endometrial Cancers: Cohort Study and Meta-Analysis. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41899533 | PubMed |
| 41595105 | Molecular Classification and Clinical Outcomes in Endometrial Cancer: Real-World Evidence from a Tertiary Care Center. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41595105 | PubMed |
| 41552063 | Mismatch Repair Deficiency Profiling and Its Impact on Management and Prognosis in Endometrial Cancer Patients: A Comprehensive Update. | Cureus | 2025 | https://conductscience.org/library/papers/41552063 | PubMed |
| 41300972 | Association Between MMR Status and Prognostic Pathological Factors in Endometrioid Endometrial Cancer-A Single-Center Retrospective Study. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41300972 | PubMed |
| 41001390 | Endometrial carcinoma in Kenya: clinical and biomarker profiles of 123 cases seen at two tertiary referral centers. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41001390 | PubMed |
| 40390959 | Prevalence of Mismatch Repair Gene Defects by Means of Immuno-histochemistry Staining for MMR Proteins in Endometrial Cancer. | J Obstet Gynaecol India | 2025 | https://conductscience.org/library/papers/40390959 | PubMed |
| 40362635 | Deficient Mismatch Repair and Microsatellite Instability in Solid Tumors. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362635 | PubMed |
| 37774076 | Mismatch Repair Protein Deficiency Does Not Affect Disease Free Survival in Type I Endometrial Carcinoma. | Asian Pac J Cancer Prev | 2023 | https://conductscience.org/library/papers/37774076 | PubMed |
| 37626765 | Mesonephric-like Adenocarcinoma of the Uterine Corpus: Genomic and Immunohistochemical Profiling with Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single Institution. | Biomedicines | 2023 | https://conductscience.org/library/papers/37626765 | PubMed |
| 37408903 | Clinicopathological characteristics of endometrial carcinomas according to DNA mismatch repair protein status. | Heliyon | 2023 | https://conductscience.org/library/papers/37408903 | PubMed |
| 35954447 | The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35954447 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MLH1 | 4292 | PubTator's text mining | https://conductscience.org/library/genes/4292 | NCBI Gene |
| MSH2 | 4436 | PubTator's text mining | https://conductscience.org/library/genes/4436 | NCBI Gene |
| MSH3 | 4437 | PubTator's text mining | https://conductscience.org/library/genes/4437 | NCBI Gene |
| MSH6 | 2956 | PubTator's text mining | https://conductscience.org/library/genes/2956 | NCBI Gene |
| PMS1 | 5378 | PubTator's text mining | https://conductscience.org/library/genes/5378 | NCBI Gene |
| PMS2 | 5395 | PubTator's text mining | https://conductscience.org/library/genes/5395 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33845554
GET https://conductscience.org/api/papers/v1/33845554/references?page=2